Immunohistochemical analysis for cytokeratin 7, KIT, and PAX2: value in the differential diagnosis of chromophobe cell carcinoma.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  American Journal of Clinical Pathology

• Publication date

  2007-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1309/9KWEA4W9Y94D1AEEPMID 17210525
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs

  2005cited by this paper
• KIT and RCC Are Useful in Distinguishing Chromophobe Renal Cell Carcinoma From the Granular Variant of Clear Cell Renal Cell Carcinoma

  2005cited by this paper
• Pax2 expression occurs in renal medullary epithelial cells in vivo and in cell culture, is osmoregulated, and promotes osmotic tolerance.

  2005cited by this paper
• Expression of aquaporins and PAX-2 compared to CD10 and cytokeratin 7 in renal neoplasms: a tissue microarray study

  2005cited by this paper
• Eosinophilic and classic chromophobe renal cell carcinomas have similar frequent losses of multiple chromosomes from among chromosomes 1, 2, 6, 10, and 17, and this pattern of genetic abnormality is not present in renal oncocytoma

  2005cited by this paper
• Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray

  2004cited by this paper
• Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma.

  2004cited by this paper
• KIT expression in fetal, normal adult, and neoplastic renal tissues

  2004cited by this paper
• Molecular cytogenetic characterization shows higher genetic homogeneity in conventional renal cell carcinoma compared to other kidney cancers.

  2004cited by this paper
• KIT Expression in Chromophobe Renal Cell Carcinoma: Comparative Immunohistochemical Analysis of KIT Expression in Different Renal Cell Neoplasms

  2004cited by this paper
• Robust Classification of Renal Cell Carcinoma Based on Gene Expression Data and Predicted Cytogenetic Profiles

  2004cited by this paper
• Overexpression of KIT in chromophobe renal cell carcinoma

  2003cited by this paper
• World Health Organization Classification of Tumours

  2002cited by this paper
• Tissue microarray molecular profiling of early, node-negative adenocarcinoma of the rectum: a comprehensive analysis.

  2002cited by this paper
• Cytokeratin 7: a useful adjunct in the diagnosis of chromophobe renal cell carcinoma

  2002cited by this paper
• Pax-2 expression in adult renal tumors.

  2001cited by this paper
• Cytogenetic characterization of 22 human renal cell tumors in relation to a histopathological classification.

  1999cited by this paper
• Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors.

  1997cited by this paper
• The Heidelberg classification of renal cell tumours

  1997cited by this paper
• THE HEIDELBERG CLASSIFICATION OF RENAL CELL TUMOURS

  1997cited by this paper
• Adult renal epithelial neoplasms.

  1995cited by this paper
• Significance of the clonal and sporadic chromosome abnormalities in nonneoplastic renal tissue

  1992cited by this paper
• Significance of the clonal and sporadic chromosome abnormalities in non-neoplastic renal tissue

  1992cited by this paper
• Chromophobe cell renal carcinoma and its variants—a report on 32 cases

  1988cited by this paper
• Human chromophobe cell renal carcinoma

  1985cited by this paper

• Immunohistochemical co-expression of PAX2 and CAIX predicts better prognosis in clear cell renal cell carcinoma after nephrectomy: A retrospective observational study.

  2024cites this paper
• The role of immunohistochemistry (PAX2 and PAX8) as prognostic markers in renal cell carcinoma

  2024cites this paper
• Scars Run Deep: Problematic Morphology and Immunoprofile of Scars in Renal Oncocytomas

  2023cites this paper
• Contemporary Clinical Definitions, Differential Diagnosis, and Novel Predictive Tools for Renal Cell Carcinoma

  2022cites this paper
• Accuracy of Subclassification and Grading of Renal Tumors on Fine Needle Aspiration Cytology Alone

  2021cites this paper
• IMPDH1/YB-1 Positive Feedback Loop Assembles Cytoophidia and Represents a Therapeutic Target in Metastatic Tumors.

  2020cites this paper
• Combined Immunohistochemistry for the “Three 7” Markers (CK7, CD117, and Claudin-7) Is Useful in the Diagnosis of Chromophobe Renal Cell Carcinoma and for the Exclusion of Mimics: Diagnostic Experience from a Single Institution

  2019cites this paper
• Utility of cytokeratin 7, S100A1 and caveolin-1 as immunohistochemical biomarkers to differentiate chromophobe renal cell carcinoma from renal oncocytoma.

  2019cites this paper
• Integrated Molecular Analysis for the Identification and Validation of Novel Biomarkers for Renal Cell Carcinoma and the Small Renal Mass

  2019cites this paper
• Next-Generation Sequencing to Detect Deletion of RB1 and ERBB4 Genes in Chromophobe Renal Cell Carcinoma: A Potential Role in Distinguishing Chromophobe Renal Cell Carcinoma from Renal Oncocytoma.

  2018cites this paper
• Are Pax proteins potential therapeutic targets in kidney disease and cancer?

  2018cites this paper
• Caspase 3 as a Novel Marker to Distinguish Chromophobe Renal Cell Carcinoma from Oncocytoma

  2018cites this paper
• The diagnostic utility of carbonic anhydrase IX, &agr;-methylacyl-coenzyme A racemase, and BSND in classifying renal cell carcinoma: an immunohistochemical study

  2017influential citation
• Pathology of Renal Cell Carcinoma

  2017cites this paper
• Expression of paired Box-2 gene product in renal tumors as a diagnostic immunomarker

  2017influential citation
• Biomarkers of Renal Tumors: the Current State and Clinical Perspectives

  2017cites this paper
• Neoplasms of the Kidney

  2016cites this paper
• Evaluating prognosis by CK7 differentiating renal cell carcinomas from oncocytomas can be used as a promising tool for optimizing diagnosis strategies

  2016cites this paper
• Incidence of Renal Cell Carcinoma among Patients with Kidney Tumours with Reference to the Expression of Ck 7 & Vimentin

  2016influential citation
• The Significance of BerEp4 and Cytokeratin 19 Expressions in Epithelial Tumors of Kidney and Renal Pelvis

  2016cites this paper
• BSND and ATP6V1G3: Novel Immunohistochemical Markers for Chromophobe Renal Cell Carcinoma

  2015cites this paper
• Sustained Response to Temsirolimus in Chromophobe variant of Metastatic Renal Cell Carcinoma

  2015cites this paper
• Upper Urinary Tract Urothelial Carcinoma Pathology

  2015cites this paper
• TGF-β1 Expression in Chromophobe Renal Cell Carcinoma and Renal Oncocytoma

  2014cites this paper
• Cytologic diagnosis of thyroid‐like follicular carcinoma of the kidney: A case report

  2014cites this paper
• Survivin Expression in Renal Epithelial Tumors: It’s Usage in the Differential Diagnosis of Eosinophilic Renal Epithelial Tumors -

  2014influential citation
• The application of immunohistochemical biomarkers in urologic surgical pathology.

  2014cites this paper
• Diagnosis of metastatic renal cell carcinoma on fine-needle aspiration cytology.

  2014cites this paper
• Ancillary Diagnostic Techniques in the Evaluation of Adult Epithelial Renal Neoplasms: Indications, Caveats, and Pitfalls

  2014cites this paper
• Deregulation of PAX2 expression in renal cell tumours: mechanisms and potential use in differential diagnosis

  2013influential citation
• Value of PAX8, PAX2, napsin A, carbonic anhydrase IX, and claudin-4 immunostaining in distinguishing pleural epithelioid mesothelioma from metastatic renal cell carcinoma

  2013cites this paper
• LMP2, a novel immunohistochemical marker to distinguish renal oncocytoma from the eosinophilic variant of chromophobe renal cell carcinoma.

  2013cites this paper
• Chapter 12 – Kidney, adrenal and retroperitoneum proper

  2012cites this paper
• Expression pattern of PAX2 in hyperplastic and malignant endometrium

  2012cites this paper
• Chromophobe renal cell carcinoma with prolonged response to targeted therapy: a case report

  2012cites this paper
• Utility of immunohistochemical analysis of KAI1, epithelial-specific antigen, and epithelial-related antigen for distinction of chromophobe renal cell carcinoma, an eosinophilic variant from renal oncocytoma

  2012cites this paper
• Immunohistochemical marker panel differentiates between the three most common subtypes of renal cell carcinoma independent from histomorphologic criteria

  2012cites this paper
• Value of PAX2 Immunostaining in Tumor Diagnosis: A Review and Update

  2012cites this paper
• Multilocular Cystic Renal Cell Carcinoma: Similarities and Differences in Immunoprofile Compared With Clear Cell Renal Cell Carcinoma

  2012cites this paper
• Protein expression and gene mutation status of KIT and PDGFRA in renal cell carcinoma.

  2012cites this paper
• Value of PAX 8 Immunostaining in Tumor Diagnosis: A Review and Update

  2012cites this paper
• PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison.

  2012cites this paper
• Malignant effusion of chromophobe renal‐cell carcinoma: Cytological and immunohistochemical findings

  2012cites this paper
• Predictors of response to targeted therapy in renal cell carcinoma.

  2012cites this paper
• Chapter 8 – Immunohistology of Metastatic Carcinomas of Unknown Primary

  2011cites this paper
• Cluster analysis of immunohistochemical profiles delineates CK7, vimentin, S100A1 and C‐kit (CD117) as an optimal panel in the differential diagnosis of renal oncocytoma from its mimics

  2011cites this paper
• Chapter 14 – Immunohistology of the Gastrointestinal Tract

  2011cites this paper
• Diffuse Expression of PAX2 and PAX8 in the Cystic Epithelium of Mixed Epithelial Stromal Tumor, Angiomyolipoma With Epithelial Cysts, and Primary Renal Synovial Sarcoma: Evidence Supporting Renal Tubular Differentiation

  2011cites this paper
• Fluorescent In-situ Hybridization Study of Non-papillary Oncocytic/Eosinophilic Renal Cell Carcinoma

  2011cites this paper
• Immunohistochemical Characterization of 13 Canine Renal Cell Carcinomas

  2011cites this paper
• The transcription factor PAX2 regulates ADAM10 expression in renal cell carcinoma.

  2011cites this paper
• Lim1, an Embryonal Transcription Factor, Is Absent in Multicystic Renal Dysplasia, but Reactivated in Nephroblastomas

  2011cites this paper
• Carbonic anhydrase IX expression in renal neoplasms: correlation with tumor type and grade.

  2010cites this paper
• Anatomic Pathology / Carbonic Anhydrase IX in Renal Tumors

  2010cites this paper
• The Utility of Pax-2 and Renal Cell Carcinoma Marker Immunohistochemistry in Distinguishing Papillary Renal Cell Carcinoma From Nonrenal Cell Neoplasms With Papillary Features

  2010cites this paper
• PAX-2 is a helpful marker for diagnosing metastatic renal cell carcinoma: comparison with the renal cell carcinoma marker antigen and kidney-specific cadherin.

  2010cites this paper
• Molecular pathology of chromophobe renal cell carcinoma: A review

  2010cites this paper
• Application of Immunohistochemistry to the Diagnosis of Kidney Tumors

  2010cites this paper
• Comparison of accuracy of 14‐, 18‐ and 20‐G needles in ex‐vivo renal mass biopsy: a prospective, blinded study

  2010cites this paper
• The Use of Immunohistochemistry in the Diagnosis of Metastatic Clear Cell Renal Cell Carcinoma: A Review of PAX-8, PAX-2, hKIM-1, RCCma, and CD10

  2010cites this paper
• Renal Neoplasms: An Update on Immunohistochemical and Histochemical Features

  2010cites this paper
• Immunohistochemical expression of tumor antigens MAGE-A3/4 and NY-ESO-1 in renal oncocytoma and chromophobe renal cell carcinoma.

  2010cites this paper
• Patrício Analysis of PAX 2 Gene Alterations in Renal Cell Tumors

  2010influential citation
• PAX-2 in the diagnosis of primary renal tumors: immunohistochemical comparison with renal cell carcinoma marker antigen and kidney-specific cadherin.

  2009cites this paper
• Diagnostic Implications of Transcription Factor Pax 2 Protein and Transmembrane Enzyme Complex Carbonic Anhydrase IX Immunoreactivity in Adult Renal Epithelial Neoplasms

  2009cites this paper
• Cytological features of chromophobe renal cell carcinoma, classic type. A report of nine cases

  2009cites this paper
• Loss of VHL and Hypoxia Provokes PAX2 Up-Regulation in Clear Cell Renal Cell Carcinoma

  2009cites this paper
• RENAL EPITHELIAL TUMORS 2009: THE ROLE OF ELECTRON MICROSCOPY IN UNDERSTANDING PATHOGENESIS, DIAGNOSIS, AND CLASSIFICATION.

  2009cites this paper
• Immunohistochemical stain for cytokeratin 7, S100A1 and claudin 8 is valuable in differential diagnosis of chromophobe renal cell carcinoma from renal oncocytoma

  2009cites this paper
• Oncocytic renal cell carcinoma with immunohistochemical properties of renal oncocytoma.

  2009cites this paper
• High-dimensional log-linear model selection with applications in molecular biology

  2009cites this paper
• Expression of PAX8 in normal and neoplastic renal tissues: an immunohistochemical study

  2009cites this paper
• Best practices in diagnostic immunohistochemistry: spindle cell neoplasms of the gastrointestinal tract.

  2009cites this paper
• In vivo validation of PAX2 as a target for renal cancer therapy.

  2008cites this paper
• Expression of PAX8 in Nephrogenic Adenoma and Clear Cell Adenocarcinoma of the Lower Urinary Tract: Evidence of Related Histogenesis?

  2008cites this paper
• Oncocytic papillary renal cell carcinoma with solid architecture: Mimic of renal oncocytoma

  2008cites this paper
• Progesterone receptor reactivity in renal oncocytoma and chromophobe renal cell carcinoma

  2008cites this paper
• Immunohistochemical Analysis for Cytokeratin 7, KIT, and PAX2: Value in the Differential Diagnosis of Chromophobe Cell CarcinomaMemeo L, Jhang J, Assaad AM, et al (Mediterranean Inst of Oncology, Catania, Italy; Columbia Univ, New York) Am J Clin Pathol 127:225–229, 2007§

  2008cites this paper
• Cytologic Features of Cancers Metastatic to the Lung and Diagnostic Usefulness of Immunohistochemistry: Distinction Between Primary and Secondary Lung Tumors.

  2008cites this paper
• The utility of Pax‐2 as an immunohistochemical marker for renal cell carcinoma in cytopathology

  2008cites this paper
• Pigmented microcystic chromophobe renal cell carcinoma.

  2007cites this paper
• Chapter 7 – Immunohistology of Metastatic Carcinoma of Unknown Primary

  2006cites this paper